Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Schneider

Showing results (1-10 of 182) with videos related to

Pageof 19
Sort By:
British Journal of Clinical Pharmacology|September 13, 2011
Anti-platelet therapy: glycoprotein IIb-IIIa antagonistsDavid J Schneider
Reviews in Cardiovascular Medicine|January 17, 2007
Platelet protagonist/antagonist: understanding the distinguishing characteristics of anticoagulantsDavid J Schneider
The Journal of Invasive Cardiology|April 11, 2013
The relationship between thrombin and platelets: linking vessel injury to thrombosis and inflammationDavid J Schneider
Coronary Artery Disease|December 2, 2005
Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistanceDavid J Schneider
Reviews in Cardiovascular Medicine|October 17, 2007
Coronary intervention in patients with diabetes, chronic renal disease, and the elderly: therapeutic implicationsDavid J Schneider
Journal of the American College of Cardiology|November 1, 2005
On defining aspirin resistanceDavid J Schneider
Thrombosis and Haemostasis|August 24, 2023
Plasma Soluble Glycoprotein VI: A Biomarker of BleedingDavid J Schneider
JACC. Cardiovascular Interventions|October 25, 2023
Effective and Safe Transition Between Intravenous and Oral P2Y<sub>12</sub> AntagonistsDavid J Schneider
JACC. Basic to Translational Science|August 22, 2024
LL-37: A Direct Link Between Inflammation and Myocardial InfarctionDavid J Schneider
Lancet (London, England)|May 27, 2015
Bivalirudin versus heparin use for patients undergoing PPCIDavid J Schneider
Pageof 19

Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
British Journal of Clinical Pharmacology|September 13, 2011
Anti-platelet therapy: glycoprotein IIb-IIIa antagonistsDavid J Schneider
Reviews in Cardiovascular Medicine|January 17, 2007
Platelet protagonist/antagonist: understanding the distinguishing characteristics of anticoagulantsDavid J Schneider
The Journal of Invasive Cardiology|April 11, 2013
The relationship between thrombin and platelets: linking vessel injury to thrombosis and inflammationDavid J Schneider
Coronary Artery Disease|December 2, 2005
Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistanceDavid J Schneider
Reviews in Cardiovascular Medicine|October 17, 2007
Coronary intervention in patients with diabetes, chronic renal disease, and the elderly: therapeutic implicationsDavid J Schneider
Journal of the American College of Cardiology|November 1, 2005
On defining aspirin resistanceDavid J Schneider
Thrombosis and Haemostasis|August 24, 2023
Plasma Soluble Glycoprotein VI: A Biomarker of BleedingDavid J Schneider
JACC. Cardiovascular Interventions|October 25, 2023
Effective and Safe Transition Between Intravenous and Oral P2Y<sub>12</sub> AntagonistsDavid J Schneider
JACC. Basic to Translational Science|August 22, 2024
LL-37: A Direct Link Between Inflammation and Myocardial InfarctionDavid J Schneider
Lancet (London, England)|May 27, 2015
Bivalirudin versus heparin use for patients undergoing PPCIDavid J Schneider
Pageof 19